Strenuous exercise is linked to an earlier onset of ALS symptoms in susceptible individuals. Heavy physical activity does not ...
AI voice analysis shows potential in detecting early signs of ALS, particularly the bulbar-onset form affecting the mouth and throat. Bulbar-onset ALS carries a poorer prognosis, making early ...
NfL changes may help predict clinical benefit with CNM-Au8 in ALS, with lower or stable levels linked to better survival and function. In post hoc analyses, CNM-Au8-treated patients whose NfL declined ...
Health Canada filing targeted for December. According to Neurosense, Health Canada raised no concerns about the proposed timeline and advised the company to target early December ...
A study found occupational exposure to pesticides significantly increases the risk of developing ALS, particularly among ...
In all this randomness and this pandemonium, you and Chidi found each other, and you had a life together. Isn’t that remarkable?” Maybe that’s the closest we can get to an answer. Todd and I built a ...
A 19-protein blood panel may help predict ALS symptom onset in mutation carriers. The panel estimated symptom timing with an average error of 1.6 years. This tool could help guide enrollment in ALS ...
Aiming to better understand what these risk factors might be, Weisskopf and colleagues set out to explore whether if ALS risk ...
My brother and his family visited from out of town for a few days, so I planned a couple activities away from home and hired a caregiver for my husband, Todd, who has ALS and is paralyzed. Now that ...
Neurosense Therapeutics announced it will seek approval in Canada for PrimeC, its oral treatment candidate for ALS. New trial data submitted to Health Canada showed a 14.9-month survival benefit with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results